The Latest on: Immunotherapy
[google_news title=”” keyword=”immunotherapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Immunotherapy
- Microbial Immunotherapy Company Prokarium Raises $30M On Heels Of Ginkgo Bioworks Partnershipon February 9, 2023 at 3:04 am
Salmonella, think Prokarium. These bacteria may cause food poisoning in one form, but engineered the right way can become living medicine — turning not fuel into fire but fire into fuel.
- TILT Biotherapeutics closes €22M financing for oncology immunotherapy trialson February 9, 2023 at 2:19 am
TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, has closed its €22 million ($23.8 million) round. This follows on from the first close of €10 ...
- Validan el uso clínico de un biomarcador predictivo tumoral para mejorar el beneficio de la inmunoterapiaon February 8, 2023 at 8:03 pm
Strata Oncology, una compañía de oncología de precisión de nueva generación que permite un tratamiento más inteligente y precoz del cáncer, ha anunciado la publicación de un nuevo estudio revisado por ...
- Buffalo-based immunotherapy company Immunaeon joins RegenMed Hub’s Innovation Acceleratoron February 8, 2023 at 10:33 am
Weeks after announcing a new program, the RegenMed Hub in Innovation Quarter is growing yet again. Buffalo-based immunotherapy company Immunaeon is the newest addition to the RegeneratOR Innovation ...
- Drugs for Immunotherapy Global Market Report 2023on February 8, 2023 at 9:22 am
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Drugs for Immunotherapy Global Market Report 2023" - https://www ...
- Immunotherapy: Why T cells don't always destroy solid tumorson February 7, 2023 at 8:25 pm
Researchers say the stress response experienced by T cells during immunotherapy can sometimes prevent them from destroying solid tumors ...
- Biomarker Algorithm May Predict Immunotherapy Outcomes Across Cancer Typeson February 7, 2023 at 2:00 pm
A new tool may identify more patients with cancer who can benefit from immunotherapy. A new study has been published which validates the clinical utility of Immunotherapy Response Scores, a tool that ...
- pH-activated nanocytokines based on IL-12 safely overcome cancer resistance to immunotherapyon February 7, 2023 at 1:25 pm
A group led by Prof. Horacio Cabral, in collaboration with a group led by Prof. Kazuhiro Kakimi, discovered a new way to improve cancer immunotherapy. Their findings are published in a paper, titled ...
- Study validates clinical utility of pan-tumor predictive biomarker for checkpoint inhibitor immunotherapy benefiton February 7, 2023 at 6:52 am
Development of an integrative immunotherapy response score (IRS) model to stratify PD-(L)1 therapy benefit in patients with advanced solid tumors. a Real-world treatment and molecular profiling data ...
via Bing News